GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+21.62%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$347M
AUM Growth
+$347M
(+64%)
Cap. Flow
+$88.9M
Cap. Flow
% of AUM
25.63%
Top 10 Holdings %
Top 10 Hldgs %
36.85%
Holding
91
New
29
Increased
17
Reduced
15
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$16.3M |
| 2 |
Abbott
ABT
|
$12.7M |
| 3 |
Puma Biotechnology
PBYI
|
$10.1M |
| 4 |
DBVT
DBV Technologies
DBVT
|
$9.08M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$8.06M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11M |
| 2 |
Medtronic
MDT
|
$8.68M |
| 3 |
BLUE
bluebird bio
BLUE
|
$7.46M |
| 4 |
Neurocrine Biosciences
NBIX
|
$5.68M |
| 5 |
CONMED
CNMD
|
$5.21M |
Sector Composition
| 1 | Healthcare | 91.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Travere Therapeutics
TVTX
$1.75B
| $5.6M | 0.91% |
+250,000
| New | +$5.6M |
|
27
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.55M | 0.9% |
60,000
-50,000
| -45% | -$4.63M |
|
|
QGENF
28
DELISTED
QIAGEN NV
QGENF
| $5.49M | 0.89% |
+200,000
| New | +$5.49M |
|
|
ACOR
29
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $5.22M | 0.85% |
2,083
-625
| -23% | -$1.57M |
|
|
AERI
30
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.72M | 0.77% |
+125,000
| New | +$4.72M |
|
31
Biogen
BIIB
$20.8B
| $4.7M | 0.76% |
15,000
-15,000
| -50% | -$4.7M |
|
32
Aclaris Therapeutics
ACRS
$223M
| $4.48M | 0.73% |
+175,000
| New | +$4.48M |
|
|
ENTL
33
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $4.44M | 0.72% |
200,000
+80,000
| +67% | +$1.77M |
|
|
PTHN
34
DELISTED
Patheon N.V.
PTHN
| $4.3M | 0.7% |
+275,700
| New | +$4.3M |
|
|
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.08M | 0.66% |
225,000
-25,000
| -10% | -$453K |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $4.07M | 0.66% |
4,632
-8,492
| -65% | -$7.46M |
|
|
ELGX
37
DELISTED
Endologix Inc
ELGX
| $3.84M | 0.62% |
30,000
-10,000
| -25% | -$1.28M |
|
|
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
| $3.72M | 0.6% |
+325,000
| New | +$3.72M |
|
39
Neurogene
NGNE
$284M
| $3.34M | 0.54% |
+12,500
| New | +$3.34M |
|
40
Thermo Fisher Scientific
TMO
$183B
| $3.18M | 0.52% |
+20,000
| New | +$3.18M |
|
|
KTWO
41
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.11M | 0.5% |
175,000
-175,000
| -50% | -$3.11M |
|
42
Exact Sciences
EXAS
$9.33B
| $2.79M | 0.45% |
+150,000
| New | +$2.79M |
|
43
Veracyte
VCYT
$2.41B
| $2.77M | 0.45% |
364,000
+22,292
| +7% | +$170K |
|
44
Akebia Therapeutics
AKBA
$827M
| $2.72M | 0.44% |
+300,000
| New | +$2.72M |
|
45
Xenon Pharmaceuticals
XENE
$2.99B
| $2.63M | 0.43% |
+325,000
| New | +$2.63M |
|
46
Rigel Pharmaceuticals
RIGL
$710M
| $2.57M | 0.42% |
70,000
-10,000
| -13% | -$367K |
|
|
NDRM
47
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.42M | 0.39% |
+131,000
| New | +$2.42M |
|
|
GHDX
48
DELISTED
Genomic Health, Inc.
GHDX
| $2.17M | 0.35% |
75,000
-125,000
| -63% | -$3.62M |
|
49
Vanda Pharmaceuticals
VNDA
$279M
| $1.85M | 0.3% |
+111,000
| New | +$1.85M |
|
|
MRTX
50
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.82M | 0.29% |
275,000
+200,000
| +267% | +$1.32M |
|